P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours-Reference-Cited by-同舟云学术

P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours

Published:2001-05 Issue:7 Volume:87 Page:661-666
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Baltaci S.,Orhan D.,Türkölmez K.,Yesilli C.,Bedük Y.,Tulunay O.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410x.2001.02151.x/fullpdf

Reference17 articles.

1. Poor-risk germ cell tumors;Dodd;Urol Clin North Am,1998

2. Apoptosis in cancer therapy: crossing the threshold;Fisher;Cell,1994

3. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax: bcl-2 ratio;Chresta;Cancer Res,1996

4. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents;Lowe;Cell,1993

5. p53 gene mutation in Chinese human testicular seminomas;Wei;J Urol,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Autophagy Always a Barrier to Cisplatin Therapy?;Biomolecules;2022-03-17

2. Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives;Cancers;2020-06-17

3. Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application;Critical Reviews in Oncology/Hematology;2014-03

4. Clinical Applications of Recent Molecular Advances in Urologic Malignancies;Advances in Anatomic Pathology;2013-05

5. Immunohistology of the Prostate, Bladder, Kidney, and Testis;Diagnostic Immunohistochemistry;2011